High prevalence and diversity of kidney dysfunction in patients with type 2 diabetes mellitus and coronary artery disease: The BARI 2D baseline data

American Journal of the Medical Sciences

Volumn 339, Issue 5, 2010, Pages 401-410

  Wall, Barry M ^a   Hardison, Regina M ^b   Molitch, Mark E ^d   Marroquin, Oscar C ^c,e   McGill, Janet B ^f   August, Phyllis A ^g  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b Graduate School of Public Health   (Australia)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^f BARNES JEWISH HOSPITAL   (United States)

^g WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Albuminuria; Chronic kidney disease; Clinical epidemiology; Clinical trial; Diabetes mellitus

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; ORAL ANTIDIABETIC AGENT; TRIACYLGLYCEROL;

ADULT; AGED; ALBUMINURIA; ARTICLE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETIC NEUROPATHY; DIASTOLIC BLOOD PRESSURE; DIET THERAPY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GLOMERULUS FILTRATION RATE; GLYCEMIC CONTROL; HEART EJECTION FRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; LOW LEVEL LASER THERAPY; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PROTEIN BLOOD LEVEL; RACE; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION; RISK ASSESSMENT; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; AGED, 80 AND OVER; ALBUMINURIA; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; KIDNEY FAILURE; MALE;

EID: 77952279378     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e3181d430ad     Document Type: Article

References (42)

1. Gross JL, de Azevedo MJ, Silveiro SP, et al. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care 2005;28:176-88.
2. United States Renal Data System. Excerpts from the USRDS 2007 annual data report: atlas of end-stage renal disease in the United States. Am J Kidney Dis 2008; 51 (suppl 1) : S1.
3. Van Dijk PC, Jager KJ, Stengel B, et al. Renal replacement therapy for diabetic end-stage renal disease: data from 10 registries in Europe (1991-2000). Kidney Int 2005;67:1489-99.
4. Pham TT, Sim JJ, Kujubu DA, et al. Prevalence of nondiabetic renal disease in diabetic patients. Am J Nephrol 2007;27:322-8.
5. Kramer HJ, Nguyen QD, Curhan G, et al. Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. JAMA 2003;289:3273-7.
6. MacIsaac RJ, Tsalamandris C, Panagiotopoulos S, et al. Nonalbuminuric renal insufficiency in type 2 diabetes. Diabetes Care 2004;27:195-200.
7. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity onset diabetes. N Engl J Med 1984;310:356-60.
8. Dinneen SF, Gerstein HC. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. Arch Intern Med 1997;157:1413-8.
9. Gerstein HC, Mann JF, Yi Q, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001;286:421-6.
10. Hillege HL, Fidler V, Diercks GFH, et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 2002;106:1777-82.
11. Klausen K, Borch-Johnsen K, Feldt-Rasmussen B, et al. Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation 2004;110:32-5.
12. Romundstad S, Holmen J, Kvenild K, et al. Microalbuminuria and all-cause mortality in 2, 089 apparently healthy individuals: a 4.4-year follow-up study. The Nord-Trondelag Health Study (HUNT), Norway. Am J Kidney Dis 2003;42:466-73.
13. Arnlov J, Evans JC, Meigs JB, et al. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation 2005;112:969-75.
14. Anavekar NS, McMurray JJ, Velazquez EJ, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004;351:1285-95.
15. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351:1296-305.
16. Henry RM, Kostense PJ, Bos G, et al. Mild renal insufficiency is associated with increased cardiovascular mortality: the Hoorn study. Kidney Int 2002;62:1402-7.
17. Fried LF, Katz R, Sarnak MJ, et al. Kidney function as a predictor of noncardiovascular mortality. J Am Soc Nephrol 2005;16:3728-35.
18. Shlipak MG, Sarnak MJ, Katz R, et al. Cystatin C and the risk of death and cardiovascular events in the elderly. N Engl J Med 2005;352:2049-60.
19. Garg Amit X, Kiberd Bryce A, Clark William, et al. Albuminuria and renal insufficiency prevalence guides population screening: Results from the NHANES III. Kidney Int 2002;61:2165-75.
20. Bypass Angioplasty Revascularization Investigation 2 Diabetes Study Group. Baseline characteristics of patients with diabetes and coronary artery disease enrolled in the BARI 2D trial. BARI 2D Investigators. Am Heart J 2008;156:528-36.
21. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999;130:461-70.
22. Eknoyan G, Hostetter T, Bakris GL, et al. Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Am J Kidney Dis 2003;42:617-22.
23. KDOQI. KDOQI Clinical Practice Guidelines and Clinical Practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis 2007; 49 (suppl 2) : S17.
24. Parving H-H, Lewis JB, Ravid M, et al. Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective. Kidney Int 2006;69:2057-63.
25. Gerstein HC, Joyce C, Mann J, et al. Prevalence and determinants of microalbuminuria in high-risk diabetic and nondiabetic patients in the Heart Outcomes Prevention Evaluation Study. Diabetes Care 2000; 23 (suppl 2) : B35-9.
26. So WY, Kong A, Ronald CW, et al. Glomerular filtration rate, cardiorenal end points, and all-cause mortality in type 2 diabetic patients. Diabetes Care 2006;29:2046-52.
27. Kramer H, Molitch ME. Screening for kidney disease in adults with diabetes. Diabetes Care 2005;28:1813-6.
28. American diabetes Association. Standards of medical care and diabetes-2006. Diabetes Care 2006; 29 (suppl) : S4-42.
29. Adler AI, Stevens RJ, Manley SE, et al. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 2003;63:225-32.
30. UK Prospective Diabetes Study Group. UK Prospective Diabetes Study (UKPDS) : urinary albumin excretion over 3 years in diet-treated type 2 (non-insulin-dependent) diabetic patients and association with hypertension, hyperglycaemia, and hypertriglyceridaemia. Diabetologia 1993;36:1021-9.
31. Rossing K, Christensen PK, Hovind P, et al. Progression of nephropathy in type 2 diabetic patients. Kidney Int 2004;66:1596-605.
32. Iseki K, Kozen K, Chiho I, et al. Relationship between predicted creatinine clearance and proteinuria and the risk of developing ESRD in Okinawa, Japan. Am J Kidney Dis 2004;44:806-14.
33. Astor BD, Hallan SI, Miller EM, et al. Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population. Am J Epidemiol 2008;167:1226-34.
34. Hallan S, Astor B, Romundsrad S, et al. Association of kidney function and albuminuria with cardiovascular mortality in older versus younger individuals. Arch Intern Med 2007;167:2490-6.
35. Viek AL, van der Geaaf Y, Spiering W, et al. Cardiovascular events and all cause mortality by albuminuria and decreased glomerular filtration rate in patients with vascular disease. J Intern Med 2008;264:351-60.
36. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA 2007;298:2038-47. (Pubitemid 350074801)
37. Gaede P, Vedel P, Larsen N, et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003;348:383-93. (Pubitemid 36159355)
38. Gaede P, Vedel P, Parving H-H, et al. Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study. Lancet 1999;353:617-22.
39. Dahl-Jorgensen K, Bjoro T, Kierulf P, et al. Long-term glycemic control and kidney function in insulin-dependent diabetes mellitus. Kidney Int 1992;41:920-3.
40. Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. The Diabetes Control and Complications (DCCT) Research Group. Kidney Int 1995;47:1703-20.
41. Nathan DM, Rosenbaum C, Protasowicki VD. Single-void samples can be used to estimate quantitative proteinuria. Diabetes Care 1987;10:414-8.
42. Schwab SJ, Dunn FL, Feinglos MN. Screening for microalbuminuria. A comparison of single sample methods of collection and techniques of albumin analysis. Diabetes Care 1992;15:1581-4.